Retrospective Analysis of Severe Neutropenia in Patients Receiving Concomitant Administration of Docetaxel and Clarithromycin

Publisher： Karger

E-ISSN： 1421-9794|59|6|407-413

ISSN： 0009-3157

Source： Chemotherapy, Vol.59, Iss.6, 2014-07, pp. : 407-413

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retrospective Analysis of the Risk Factors for Grade IV Neutropenia in Oesophageal Cancer Patients Treated with a Docetaxel, Cisplatin, and 5-Fluorouracil Regimen

By  

Chemotherapy, Vol. 62, Iss. 4, 2017-04 ,pp. : 215-224

Karger

Access to resources Recommend Favorite

Risk Factors for Predicting Severe Neutropenia Induced by Amrubicin in Patients with Advanced Lung Cancer

By  

Chemotherapy, Vol. 58, Iss. 6, 2013-01 ,pp. : 419-425

Karger

Access to resources Recommend Favorite

Phase I Trial Using Weekly Administration of Gemcitabine and Docetaxel in Patients with Advanced Pancreatic Carcinoma

By  

Chemotherapy, Vol. 50, Iss. 6, 2004-12 ,pp. : 289-296

Karger

Access to resources Recommend Favorite

Retrospective Analysis of Vancomycin Nephrotoxicity in Elderly Chinese Patients

By  

Pharmacology, Vol. 95, Iss. 5-6, 2015-05 ,pp. : 279-284

Karger

Access to resources Recommend Favorite

Post-Progression Survival Associated with Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Docetaxel Monotherapy as Second-Line Chemotherapy

By  

Chemotherapy, Vol. 62, Iss. 4, 2017-04 ,pp. : 205-213

Karger

Access to resources Recommend Favorite